{"id":44348,"date":"2025-10-07T09:14:34","date_gmt":"2025-10-07T12:14:34","guid":{"rendered":"https:\/\/phelcom.com\/?p=44348"},"modified":"2026-03-23T15:05:59","modified_gmt":"2026-03-23T18:05:59","slug":"premio-veja-saude-oncoclinicas-de-inovacao-medica-2025","status":"publish","type":"post","link":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/","title":{"rendered":"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p>Desenvolvido por pesquisadores da Universidade Federal de S\u00e3o Paulo (Unifesp), o projeto \u201cRevolu\u00e7\u00e3o na retina: IA e telemedicina levam diagn\u00f3stico r\u00e1pido a pacientes com diabetes\u201d foi um dos vencedores do Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025, na categoria Tecnologias Diagn\u00f3sticas \u2014 um dos mais importantes reconhecimentos nacionais na \u00e1rea da sa\u00fade. Os vencedores foram anunciados em 5 de setembro.<\/p>\n\n\n\n<p>A iniciativa representa um avan\u00e7o significativo no rastreamento da retinopatia diab\u00e9tica, uma das principais causas de defici\u00eancia visual e cegueira no mundo. A doen\u00e7a \u00e9 uma complica\u00e7\u00e3o comum do diabetes, mas pode ser prevenida com diagn\u00f3stico e tratamento precoces.<\/p>\n\n\n\n<p>O rastreamento peri\u00f3dico com exames de fundo de olho \u00e9 essencial para identificar a doen\u00e7a em suas fases iniciais e evitar danos irrevers\u00edveis \u00e0 vis\u00e3o \u2014 um grande desafio no Brasil, especialmente na rede p\u00fablica de sa\u00fade.<\/p>\n\n\n\n<p>\u201cEnxergo esse reconhecimento com enorme relev\u00e2ncia, por representar uma linha bastante inovadora: a implementa\u00e7\u00e3o de dispositivos inteligentes e seu impacto positivo em desfechos de sa\u00fade\u201d, afirma o oftalmologista e um dos pesquisadores respons\u00e1veis pelo projeto, Fernando Korn Malerbi.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_premio_Veja_Saude_vencedores_2025-1024x683.jpg\" alt=\"Img Premio Veja Saude Vencedores 2025\" class=\"wp-image-44349\" srcset=\"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_premio_Veja_Saude_vencedores_2025-980x653.jpg 980w, https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_premio_Veja_Saude_vencedores_2025-480x320.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p class=\"has-text-align-center\">Vencedores do Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Tecnologia nacional e impacto real<\/h2>\n\n\n\n<p><\/p>\n\n\n\n<p>O estudo foi conduzido no Centro de Diabetes da Unifesp, em 2024, utilizando o <a href=\"https:\/\/phelcom.com\/pt-br\/produtos\/eyer\/\">retin\u00f3grafo port\u00e1til Eyer<\/a>. O equipamento permite a captura de imagens de alta defini\u00e7\u00e3o do fundo do olho e integra-se ao <a href=\"https:\/\/phelcom.com\/pt-br\/produtos\/eyercloud\/\">EyerCloud<\/a>, plataforma online para o gerenciamento de exames. O sistema tamb\u00e9m utiliza o <a href=\"https:\/\/phelcom.com\/pt-br\/produtos\/eyermaps\/\">EyerMaps<\/a>, uma intelig\u00eancia artificial capaz de identificar poss\u00edveis anomalias na retina em poucos segundos.<\/p>\n\n\n\n<p>As informa\u00e7\u00f5es coletadas eram analisadas por especialistas de forma remota, o que reduzia etapas e acelerava o diagn\u00f3stico.<\/p>\n\n\n\n<p>No total, 801 pacientes com diabetes participaram da triagem e quase 15% apresentaram sinais de retinopatia diab\u00e9tica. Malerbi destaca que a ades\u00e3o \u00e0s consultas de seguimento beirou 100%, demonstrando alto engajamento e confian\u00e7a no processo.<\/p>\n\n\n\n<p>O tempo m\u00e9dio entre o exame e o in\u00edcio do tratamento caiu de 20 para 9 dias, representando um avan\u00e7o decisivo em uma condi\u00e7\u00e3o considerada tempo-sens\u00edvel. \u201cReduzir o intervalo entre o diagn\u00f3stico e o tratamento \u00e9 fundamental na retinopatia diab\u00e9tica, uma vez que o atraso pode significar perda visual irrevers\u00edvel\u201d, explica.<\/p>\n\n\n\n<p>Segundo ele, o projeto gerou benef\u00edcios como maior efici\u00eancia no rastreamento, otimiza\u00e7\u00e3o de recursos, alta ades\u00e3o dos pacientes, redu\u00e7\u00e3o dos tempos de espera e satisfa\u00e7\u00e3o da equipe envolvida.<\/p>\n\n\n\n<p>\u201cA solu\u00e7\u00e3o aplicada \u00e9 100% brasileira e a pesquisa foi desenvolvida em um ambiente p\u00fablico, dentro de uma universidade federal. Isso refor\u00e7a o potencial de inova\u00e7\u00e3o cient\u00edfica e tecnol\u00f3gica existente no pa\u00eds, especialmente quando unimos a academia \u00e0 pr\u00e1tica cl\u00ednica\u201d, ressalta Malerbi.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Desafios e pr\u00f3ximos passos<\/h2>\n\n\n\n<p><\/p>\n\n\n\n<p>Embora o estudo tenha sido vi\u00e1vel em ambiente de pesquisa, Malerbi reconhece os desafios para ampliar a implementa\u00e7\u00e3o do modelo fora da universidade. \u201cDentro de um ambiente acad\u00eamico, foi relativamente simples desenhar e executar o projeto. No entanto, acreditamos que uma das maiores dificuldades em larga escala esteja na forma\u00e7\u00e3o de profissionais capacitados para a obten\u00e7\u00e3o das imagens e elabora\u00e7\u00e3o dos laudos, al\u00e9m do desenho de um fluxo cl\u00ednico eficiente em sistemas de sa\u00fade mais complexos\u201d, avalia.<\/p>\n\n\n\n<p>O oftalmologista refor\u00e7a que os pr\u00f3ximos passos s\u00e3o transformar o projeto em rotina assistencial e apoiar sua replica\u00e7\u00e3o em outros servi\u00e7os p\u00fablicos e privados. \u201cPretendemos criar condi\u00e7\u00f5es para que o projeto se torne parte do atendimento regular e tamb\u00e9m oferecer subs\u00eddios para que nossa experi\u00eancia possa ser aplicada em sistemas de sa\u00fade mais abrangentes\u201d, conclui.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pr\u00eamio<\/h2>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_premio_Veja_Saude-1024x683.jpg\" alt=\"Img Premio Veja Saude\" class=\"wp-image-44352\" srcset=\"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_premio_Veja_Saude-980x653.jpg 980w, https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_premio_Veja_Saude-480x320.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p class=\"has-text-align-center\">Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>O Pr\u00eamio Veja Sa\u00fade Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica, com curadoria da VEJA SA\u00daDE, reconhece projetos, institui\u00e7\u00f5es e profissionais que contribuem de forma significativa para o avan\u00e7o cient\u00edfico, cl\u00ednico e assistencial na \u00e1rea da sa\u00fade.<\/p>\n\n\n\n<p>A iniciativa valoriza trabalhos conduzidos, publicados ou liderados por m\u00e9dicos e cientistas brasileiros, abrangendo estudos cl\u00ednicos, testes laboratoriais, projetos educativos e assistenciais, campanhas de preven\u00e7\u00e3o e solu\u00e7\u00f5es desenvolvidas por healthtechs, dentre outros.<\/p>\n\n\n\n<p>Os projetos finalizados e com resultados consolidados que atendem aos crit\u00e9rios do regulamento s\u00e3o avaliados por um j\u00fari de especialistas. Com base nessas an\u00e1lises, s\u00e3o definidos os vencedores em cada categoria: Medicina de Precis\u00e3o e Gen\u00f4mica, Preven\u00e7\u00e3o e Promo\u00e7\u00e3o da Sa\u00fade, Tecnologias Diagn\u00f3sticas, Terapias e Tratamentos Inovadores, Medicina Social, Engajamento e Empoderamento do Paciente e IA na Transforma\u00e7\u00e3o Digital em Sa\u00fade.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vencedor na categoria \u201cTecnologias Diagn\u00f3sticas\u201d, estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer \u2014 integrado \u00e0 nuvem e \u00e0 IA EyerMaps \u2014 mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares. <\/p>\n","protected":false},"author":3,"featured_media":44359,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[106],"tags":[122],"class_list":["post-44348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-social","tag-home"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025 - PHELCOM Technologies<\/title>\n<meta name=\"description\" content=\"Estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025 - PHELCOM Technologies\" \/>\n<meta property=\"og:description\" content=\"Estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"PHELCOM Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/phelcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T12:14:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-23T18:05:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_blog_malerbi-1024x542.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"542\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gabriela Marques\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriela Marques\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/\"},\"author\":{\"name\":\"Gabriela Marques\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/person\\\/4e0e58359256b5df6d71d632d2fbdd20\"},\"headline\":\"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025\",\"datePublished\":\"2025-10-07T12:14:34+00:00\",\"dateModified\":\"2026-03-23T18:05:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/\"},\"wordCount\":828,\"publisher\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/img_blog_malerbi.jpg\",\"keywords\":[\"home\"],\"articleSection\":[\"Social\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/\",\"name\":\"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025 - PHELCOM Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/img_blog_malerbi.jpg\",\"datePublished\":\"2025-10-07T12:14:34+00:00\",\"dateModified\":\"2026-03-23T18:05:59+00:00\",\"description\":\"Estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/img_blog_malerbi.jpg\",\"contentUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/img_blog_malerbi.jpg\",\"width\":2550,\"height\":1350,\"caption\":\"Img Blog Malerbi\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/social\\\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/\",\"name\":\"PHELCOM Technologies\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\",\"name\":\"Phelcom\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/color_horizontal.png\",\"contentUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/color_horizontal.png\",\"width\":245,\"height\":40,\"caption\":\"Phelcom\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/phelcom\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/phelcom-technologies\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCSZCLEV9ZrbGBie0R0IxQpA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/person\\\/4e0e58359256b5df6d71d632d2fbdd20\",\"name\":\"Gabriela Marques\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025 - PHELCOM Technologies","description":"Estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/","og_locale":"pt_BR","og_type":"article","og_title":"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025 - PHELCOM Technologies","og_description":"Estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares.","og_url":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/","og_site_name":"PHELCOM Technologies","article_publisher":"https:\/\/www.facebook.com\/phelcom\/","article_published_time":"2025-10-07T12:14:34+00:00","article_modified_time":"2026-03-23T18:05:59+00:00","og_image":[{"width":1024,"height":542,"url":"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_blog_malerbi-1024x542.jpg","type":"image\/jpeg"}],"author":"Gabriela Marques","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gabriela Marques","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#article","isPartOf":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/"},"author":{"name":"Gabriela Marques","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/person\/4e0e58359256b5df6d71d632d2fbdd20"},"headline":"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025","datePublished":"2025-10-07T12:14:34+00:00","dateModified":"2026-03-23T18:05:59+00:00","mainEntityOfPage":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/"},"wordCount":828,"publisher":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_blog_malerbi.jpg","keywords":["home"],"articleSection":["Social"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/","url":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/","name":"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025 - PHELCOM Technologies","isPartOf":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#primaryimage"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_blog_malerbi.jpg","datePublished":"2025-10-07T12:14:34+00:00","dateModified":"2026-03-23T18:05:59+00:00","description":"Estudo da Unifesp com o retin\u00f3grafo port\u00e1til Eyer mostrou otimiza\u00e7\u00e3o da jornada do paciente com diabetes e altera\u00e7\u00f5es oculares.","breadcrumb":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#primaryimage","url":"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_blog_malerbi.jpg","contentUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2025\/10\/img_blog_malerbi.jpg","width":2550,"height":1350,"caption":"Img Blog Malerbi"},{"@type":"BreadcrumbList","@id":"https:\/\/phelcom.com\/pt-br\/blog\/social\/premio-veja-saude-oncoclinicas-de-inovacao-medica-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/phelcom.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Projeto com IA e telemedicina para detec\u00e7\u00e3o da retinopatia diab\u00e9tica vence Pr\u00eamio Veja Sa\u00fade &amp; Oncocl\u00ednicas de Inova\u00e7\u00e3o M\u00e9dica 2025"}]},{"@type":"WebSite","@id":"https:\/\/phelcom.com\/pt-br\/en\/#website","url":"https:\/\/phelcom.com\/pt-br\/en\/","name":"PHELCOM Technologies","description":"","publisher":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/phelcom.com\/pt-br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization","name":"Phelcom","url":"https:\/\/phelcom.com\/pt-br\/en\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/logo\/image\/","url":"https:\/\/phelcom.com\/wp-content\/uploads\/2018\/07\/color_horizontal.png","contentUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2018\/07\/color_horizontal.png","width":245,"height":40,"caption":"Phelcom"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/phelcom\/","https:\/\/www.linkedin.com\/company\/phelcom-technologies","https:\/\/www.youtube.com\/channel\/UCSZCLEV9ZrbGBie0R0IxQpA"]},{"@type":"Person","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/person\/4e0e58359256b5df6d71d632d2fbdd20","name":"Gabriela Marques"}]}},"_links":{"self":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/44348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/comments?post=44348"}],"version-history":[{"count":2,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/44348\/revisions"}],"predecessor-version":[{"id":48833,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/44348\/revisions\/48833"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/media\/44359"}],"wp:attachment":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/media?parent=44348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/categories?post=44348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/tags?post=44348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}